Substance / Medication

Bedaquiline fumarate

Overview

Clinical overview including description, indications, and evidence base is pending physician authorship or FDA SPL integration. Graph-derived relationship data is available below.

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Research Evidence

Published studies and systematic reviews

Sort:
Effect of High-Fat Diets on the Pharmacokinetics of Bedaquiline Fumarate Tablet: A Trial in Healthy Chinese Participants.
Wang Xuanxuan, Zhao Xiaoyu, Yang Shaomei et al. · Clin Pharmacol Drug Dev · 2025
PMID: 39865779RCT
Bioequivalence Study of Bedaquiline Fumarate Tablets in Healthy Chinese Subjects.
Yang Man, Pei Yingzi, Chen Chen et al. · Clin Pharmacol Drug Dev · 2025
PMID: 39828937RCT
Characterization of stress degradation products of bedaquiline fumarate and bedaquiline by LC-PDA and LC-MS.
Guo Kaijing, Wang Yanan, Ma Chen · J Pharm Biomed Anal · 2023
PMID: 37619292Other
Separation and Characterization of the Related Substances of Bedaquiline Fumarate Using HPLC and Spectral Methods.
Baksam Vijaya Kumar, Nimmakayala Saritha, Pocha Vasundara Reddy et al. · J Chromatogr Sci · 2022
PMID: 34864923Other
Bedaquiline fumarate microemulsion: formulation optimization, rheological characterization andstudies.
Pardhi Vishwas P, Suthar Teeja, Sharma Ankita et al. · Nanomedicine (Lond) · 2022
PMID: 36416115Other
evaluation of poloxamerforming gels for bedaquiline fumarate salt and pharmacokinetics following intramuscular injection in rats.
Hemelryck Sandy Van, Dewulf Jonatan, Niekus Harm et al. · Int J Pharm X · 2019
PMID: 31517281OtherFull text (PMC)
Formulation development, characterization, and evaluation of bedaquiline fumarate - Soluplus- solid dispersion.
Pardhi Vishwas P, Patel Manisha, Jain Keerti · Pharm Dev Technol · 2024
PMID: 38682603Preclinical
Comparison of pharmacokinetics and bioavailability of bedaquiline fumarate, benzoate and maleate in dogs.
Jaw-Tsai S, Barry R, Pande P G et al. · Int J Tuberc Lung Dis · 2023
PMID: 36853125PreclinicalFull text (PMC)

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Bedaquiline fumarate (substance)
SNOMED CT
1010553003
UMLS CUI
C3530515

Clinical Data

This intervention maps to 1 entities in the Ltrl knowledge graph.

1
Conditions
0
Biomarkers
0
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.